Related Experiment Video
Updated: Aug 14, 2026

Assessment of Selective mRNA Translation in Mammalian Cells by Polysome Profiling
Published on: October 28, 2014
Short interfering RNA against the PDCD5 attenuates cell apoptosis and caspase-3 activity induced by Bax
1Laboratory of Medical Immunology, School of Basic Medical Science, Peking University Health Science Center, 38 Xueyuan Road, Beijing, 100083, People's Republic of China.
Abstract:
The programmed cell death 5 (PDCD5) protein plays an important apoptosis-accelerating role in cells undergoing apoptosis. Decreased expression of PDCD5 has been detected in various human carcinomas. Here we describe that one potent short interfering RNA (siRNA) against the PDCD5 (siPDCD5) specifically inhibits the expression of PDCD5 at both the mRNA and protein level. Cells with decreased PDCD5 expression displayed reduced sensitivity to an apoptotic stimulus induced by Bax overexpression in HeLa, HEK293 and 293T cell lines. Furthermore, we also show that siPDCD5 inhibited both caspase-3 activity and procaspase-3 cleavage. Suppressed expression of PDCD5 attenuates the release of cytochrome c from mitochondria to cytosol induced by Bax overexpression. This phenomenon is accompanied by the reduced translocation of Bax from the cytosol to mitochondria. MTT assay shows that targeted suppression of PDCD5 expression markedly promoted cell proliferation in Hela and HEK293 cell lines. Our data suggests that PDCD5 may exert its effects through pathway of mitochondria by modulating Bax translocation, cytochrome c release and caspase 3 activation directly or indirectly, and that decreased PDCD5 expression may be one of the mechanisms by which tumor cells achieve resistance to apoptotic stimulus induced by anticancer drugs.
Insights
Programmed cell death 5 (PDCD5) protein accelerates apoptosis. Inhibiting PDCD5 reduces apoptosis sensitivity and promotes cell proliferation, suggesting its role in cancer resistance.
Area of Science:
- Cell Biology
- Molecular Biology
- Cancer Research
Background:
- Programmed cell death 5 (PDCD5) is crucial for apoptosis.
- Reduced PDCD5 expression is observed in human carcinomas.
- PDCD5's role in apoptosis regulation and cancer warrants further investigation.
Purpose of the Study:
- To investigate the functional role of PDCD5 in apoptosis.
- To determine the effect of PDCD5 suppression on apoptosis sensitivity and cell proliferation.
- To elucidate the molecular mechanisms underlying PDCD5's function in apoptosis.
Main Methods:
- Utilized short interfering RNA (siRNA) targeting PDCD5 (siPDCD5) to inhibit PDCD5 expression at mRNA and protein levels.
- Assessed apoptosis sensitivity using Bax overexpression in HeLa, HEK293, and 293T cell lines.
- Measured caspase-3 activity, procaspase-3 cleavage, cytochrome c release, and Bax translocation.
- Performed MTT assays to evaluate cell proliferation.
Main Results:
- siPDCD5 specifically inhibited PDCD5 expression.
- Decreased PDCD5 expression reduced sensitivity to apoptosis induced by Bax overexpression.
- siPDCD5 suppressed caspase-3 activity and procaspase-3 cleavage.
- PDCD5 suppression attenuated cytochrome c release and Bax translocation to mitochondria.
- Targeted PDCD5 suppression promoted cell proliferation.
Conclusions:
- PDCD5 regulates apoptosis via the mitochondrial pathway, modulating Bax translocation, cytochrome c release, and caspase-3 activation.
- Decreased PDCD5 expression may contribute to tumor cell resistance to apoptosis induced by anticancer drugs.
- PDCD5 is a potential therapeutic target for overcoming cancer drug resistance.
Related Concept Videos
Caspases
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
Experimental RNAi
Cellular Injury V: Apoptosis and Autophagy
Abnormal Proliferation
